Veracyte (VCYT) Fell Due to a Lack of Rising Profitability
Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” first quarter 2024 investor letter. A copy of the letter can be downloaded here.
Veracyte Inc. (VCYT)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | ARK Investment Management Catherine D. Wood | 6,809,297 | $147,557,471 | -4% | 1.3% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $16.33 | 60,000 | Officer, Director | 159,761 | 2022-06-10 | Filing | |
| $35.19 | 2,000 | Director | 2,000 | 2021-06-03 | Filing | |
| $5.32 | 2,500 | Officer, Director | 10,000 | 2016-06-03 | Filing | |
| $5.48 | 2,500 | Officer, Director | 7,500 | 2016-06-02 | Filing | |
| $5.46 | 2,500 | Officer, Director | 5,000 | 2016-06-01 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $25.00 | 7,500 | Director | 33,228 | 2024-07-16 | Filing | |
| $25.00 | 1,277 | Officer | 82,968 | 2024-07-16 | Filing | |
| $25.00 | 2,500 | Director | 32,878 | 2024-07-16 | Filing | |
| $24.00 | 2,500 | Director | 35,378 | 2024-07-16 | Filing | |
| $20.59 | 3,870 | Director | 29,255 | 2024-06-11 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 7,161,866 | $197,022,935 | 0% | |
| 2. | 7,118,211 | $195,821,985 | 0% | |
| 3. | 7,068,435 | $194,452,647 | 0.03% | |
| 4. | 3,372,703 | $92,786,995 | 0.02% | |
| 5. | 3,217,728 | $88,519,697 | 0.13% |
News See All
Veracyte, Inc. (NASDAQ:VCYT) Q1 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by and welcome to the Veracyte First Quarter 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
What Makes Veracyte (VCYT) a Lucrative Investment?
Next Century Growth Investors, LLC, an investment Management Company, released its “Micro-Cap Strategy” fourth-quarter investor letter. A copy of the letter can be downloaded here.
Veracyte, Inc. (NASDAQ:VCYT) Q4 2023 Earnings Call Transcript
Veracyte, Inc. misses on earnings expectations. Reported EPS is $-0.39 EPS, expectations were $-0.07. Veracyte, Inc.
Veracyte, Inc. (NASDAQ:VCYT) Q3 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Veracyte Third Quarter 2023 Financial Results Webcast. At this time all participants are in a listen-only mode.
16 Best Stocks to Buy and Hold for the Next 15 Years According to Cathie Wood's Portfolio
In this article, we will take a look at the 16 best stocks to buy and hold for the next 15 years according to Cathie Wood's portfolio.
Veracyte, Inc. (NASDAQ:VCYT) Q2 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Veracyte Second Quarter 2023 Financial Results Conference Call. [Operator Instructions].
Veracyte, Inc. (NASDAQ:VCYT) Q1 2023 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Veracyte First Quarter 2023 Financial Results Webcast. At this time, all participants are in listen-only mode.
Veracyte, Inc. (NASDAQ:VCYT) Q4 2022 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Veracyte Fourth Quarter and Full Year 2022 Financial Results Webcast. At this time, all participants are in a listen-only mode.
4 Cheap Stocks to Buy According to Cathie Wood
ARK increased its holding in Twist Bioscience by 7% in the third quarter of this year, ending the period with 6.8 million shares of the company, worth $235.3 million.